Remissio Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
Remissio General Information
Description
Developer of immunotherapies using artificial intelligence intended to provide cancer treatments. The company's technology uses vast amounts of experimental data to generate a holistic prediction of the effects of immunotherapy on patients, enabling physicians to remove patient outcomes and strengthen the patient's immune cells to fight cancer.
Contact Information
Website
www.remissio.coCorporate Office
- Lohmühlenstr. 65
- 12435 Berlin
- Germany
Corporate Office
- Lohmühlenstr. 65
- 12435 Berlin
- Germany
Remissio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 13-Jan-2021 | Completed | Bankruptcy: Liquidation | |||
| 3. Accelerator/Incubator | 25-Jun-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2020 | $98.7K | Completed | Startup | ||
| 1. Accelerator/Incubator | 25-Sep-2019 | $98.7K | $98.7K | Completed | Startup |
Remissio FAQs
-
When was Remissio founded?
Remissio was founded in 2019.
-
Where is Remissio headquartered?
Remissio is headquartered in Berlin, Germany.
-
What industry is Remissio in?
Remissio’s primary industry is Other Healthcare Technology Systems.
-
Is Remissio a private or public company?
Remissio is a Private company.
-
What is Remissio’s current revenue?
The current revenue for Remissio is .
-
How much funding has Remissio raised over time?
Remissio has raised $98.7K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process